PDE4A and systemic sclerosis: One intriguing possible implication of this result for patients with SSc is the baseline presence of a suite of endogenous cAMP‐generating ligands within the fibrotic microenvironments of the lungs and skin whose combined actions are nullified by continuous PDE4‐mediated degradation of cAMP.